ロード中...
Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI
BACKGROUND: Ferumoxytol is approved for use in the treatment of iron deficiency anemia, but it can serve as an alternative to gadolinium-based contrast agents. On the basis of postmarketing surveillance data, the Food and Drug Administration issued a black box warning regarding the risks of rare but...
保存先:
| 出版年: | Radiology |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Radiological Society of North America
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6884068/ https://ncbi.nlm.nih.gov/pubmed/31638489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1148/radiol.2019190477 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|